Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Market Drivers : Growth is driven by the rising prevalence of obesity and Type 2 diabetes, the shift toward incretin-based therapies, expanding clinical evidence of weight-loss benefits, and improved patient awareness, supported by physician advocacy and digital health engagement
Recently, some patients have reported stomach paralysis, which can lead to excessive vomiting and suicidal thoughts
Similarly, there are no generic versions of Mounjaro or Zepbound , which use the active ingredient tirzepatide
A patient who develops an illness or injury linked to the peptide could claim negligence or lack of informed consent
US$ 25.23
US$ 22.29
US$ 22.05
US$ 29.70
